Causal Effect of Plasma Fatty Acid Profiles on Psoriasis Risk: Genetic Evidence from a Mendelian Randomization Study

Area of Science:

• Nutritional Science
• Dermatology
• Genetics

Background:

• Psoriasis is a chronic inflammatory skin condition.
• Omega-3 fatty acids, abundant in fish oil, are emerging as potential dietary supplements for managing psoriasis.
• Clinical studies suggest a link between improved psoriasis and higher docosahexaenoic acid (DHA) levels, but causality is unclear.

Purpose of the Study:

• To investigate the causal relationship between circulating fatty acid levels and psoriasis risk.
• To assess the effects of various fatty acids, including omega-3s, polyunsaturated fatty acids (PUFAs), and specific components like DHA, EPA, and DPA, on psoriasis development.

Main Methods:

• Utilized summary-level data from genome-wide association studies (GWAS).
• Employed univariable (UVMR) and multivariable (MVMR) Mendelian randomization analyses.
• Assessed causal effects of multiple fatty acids on psoriasis risk.

Main Results:

• Elevated omega-3 fatty acid levels were significantly associated with a reduced risk of psoriasis (UVMR: OR = 0.900, p = 0.022; MVMR: OR = 0.862, p = 0.007).
• Docosahexaenoic acid (DHA) was identified as the primary driver of this inverse association (UVMR: OR = 0.788, p = 0.006; MVMR: OR = 0.856, p = 0.021).
• Sensitivity analyses confirmed the robustness of these findings across different Mendelian randomization methods.

Conclusions:

• This study provides genetic evidence supporting a protective role of omega-3 fatty acids against psoriasis.
• Findings suggest potential for targeted nutritional strategies in psoriasis prevention and management.
• Further research is needed to validate these results and explore clinical applications.